Pedro Castanheira Selected Research

Monoterpenes (Monoterpenoids)

6/2014

Dose-dependent inhibition of BACE-1 by the monoterpenoid 2,3,4,4-tetramethyl-5-methylenecyclopent-2-enone in cellular and mouse models of Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pedro Castanheira Research Topics

Disease

2	Lafora Disease 02/2016 - 06/2010
1	Sarcoma (Soft Tissue Sarcoma) 01/2024
1	Breast Neoplasms (Breast Cancer) 09/2019
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 02/2016
1	Amyloidosis 03/2015
1	Familial Amyloid Neuropathies (Familial Amyloid Polyneuropathy) 03/2015
1	Parkinson Disease (Parkinson's Disease) 03/2015
1	Cardiomyopathies (Cardiomyopathy) 03/2015
1	Alzheimer Disease (Alzheimer's Disease) 06/2014

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 09/2019 - 06/2014
2	ADP-Ribosylation Factors (ADP-Ribosylation Factor)IBA 01/2024 - 09/2019
2	Amyloid (Amyloid Fibrils)IBA 03/2015 - 06/2014
1	GTP-Binding Proteins (G-Protein)IBA 01/2024
1	GTP Phosphohydrolases (GTPases)IBA 01/2024
1	IntegrinsIBA 09/2019
1	PolymersIBA 02/2016
1	GlycogenIBA 02/2016
1	Prealbumin (Transthyretin)IBA 03/2015
1	Monoterpenes (Monoterpenoids)IBA 06/2014
1	Peptide Hydrolases (Proteases)FDA Link 06/2014
1	2,3,4,4- tetramethyl- 5- methylenecyclopent- 2- enoneIBA 06/2014

Therapy/Procedure

1	Therapeutics 06/2010